Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
The proposed shift of marijuana to a Schedule III drug highlights its recognized medical applications and potential to treat conditions like anxiety and chronic pain, offering a safer alternative to traditional treatments.
Family Medicine/General Practice May 14th 2024